& nbsp; < em > New Categories of Minimal Residual Disease (MRD) Negativity < /em > < /p > < p align="center" > < em > & nbsp;Provide Clinical Trial Endpoints and Framework for Cure < /em > < /p >..."> & nbsp; < em > New Categories of Minimal Residual Disease (MRD) Negativity < /em > < /p > < p align="center" > < em > & nbsp;Provide Clinical Trial Endpoints and Framework for Cure < /em > < /p >..." /> & nbsp; < em > New Categories of Minimal Residual Disease (MRD) Negativity < /em > < /p > < p align="center" > < em > & nbsp;Provide Clinical Trial Endpoints and Framework for Cure < /em > < /p >..." />

The IMF's International Myeloma Working Group Establishes Updated Yardstick for Disease Assessment in the Evolving Treatment Landscape of 2016

< p align="center" > & nbsp; < em > New Categories of Minimal Residual Disease (MRD) Negativity < /em > < /p > < p align="center" > < em > & nbsp;Provide Clinical Trial Endpoints and Framework for Cure < /em > < /p >
Source: International Myeloma Foundation - Category: Hematology Source Type: news